CGT
AGIO icon

Capital Guardian Trust’s Agios Pharmaceuticals AGIO Stock Holding History

Capital Guardian Trust’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$24.2M Sell
484,759
-162,601
-25% -$8.69M 0.33% 107
2019
Q1 		$44.1M Buy
647,360
+16,981
+3% +$989K 0.59% 75
2018
Q4 		$29.1M Sell
630,379
-15,533
-2% -$959K 0.46% 86
2018
Q3 		$49.8M Sell
645,912
-97
-0% -$7.8K 0.67% 65
2018
Q2 		$54.4M Sell
646,009
-15,253
-2% -$1.33M 0.78% 52
2018
Q1 		$54.1M Sell
661,262
-1,827
-0.3% -$141K 0.76% 52
2017
Q4 		$37.9M Sell
663,089
-66,625
-9% -$4.19M 0.54% 75
2017
Q3 		$48.7M Sell
729,714
-51,086
-7% -$3.07M 0.85% 44
2017
Q2 		$40.2M Sell
780,800
-154,079
-16% -$7.88M 0.74% 56
2017
Q1 		$54.6M Buy
934,879
+118,679
+15% +$5.69M 0.41% 88
2016
Q4 		$34.1M Buy
816,200
+176,000
+27% +$9.24M 0.27% 114
2016
Q3 		$33.8M Sell
640,200
-27,900
-4% -$1.22M 0.26% 117
2016
Q2 		$28M Buy
668,100
+244,178
+58% +$12.1M 0.22% 125
2016
Q1 		$17.2M Sell
423,922
-10,419
-2% -$445K 0.13% 150
2015
Q4 		$28.2M Buy
434,341
+19,551
+5% +$1.28M 0.22% 128
2015
Q3 		$29.3M Sell
414,790
-310,990
-43% -$30.4M 0.24% 123
2015
Q2 		$80.7M Sell
725,780
-33,476
-4% -$3.61M 0.58% 61
2015
Q1 		$71.6M Buy
759,256
+84,366
+13% +$9.45M 0.53% 72
2014
Q4 		$75.6M Buy
+674,890
New +$60.3M 0.52% 68

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Guardian Trust's AGIO Position: Q2 2019 in Review

Capital Guardian Trust reduced its Agios Pharmaceuticals (AGIO) stake by 25% in Q2 2019, selling an estimated $8.69M and leaving 484,759 shares worth $24.2M. The position accounts for 0.33% of the portfolio, ranked #107.

Capital Guardian Trust first reported a position in AGIO in Q4 2014 and has held it in 19 quarters since. The position peaked at $80.7M in Q2 2015. 189 funds tracked by Wall St. Rank hold AGIO as of Q2 2019.

  • Capital Guardian Trust held 484,759 shares of Agios Pharmaceuticals worth $24.2M as of Q2 2019.
  • Capital Guardian Trust sold 162,601 Agios Pharmaceuticals shares in Q2 2019, an estimated $8.69M.
  • Agios Pharmaceuticals made up 0.33% of Capital Guardian Trust's portfolio in Q2 2019, its #107 holding.
  • Capital Guardian Trust first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 19 quarters since.
  • Capital Guardian Trust's Agios Pharmaceuticals position peaked at $80.7M in Q2 2015.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.